Pola-R-CHP May Reverse Outlook in High-Risk Lymphoma ...Middle East

Medscape - News
Pola-R-CHP May Reverse Outlook in High-Risk Lymphoma
Analysis of the POLARIX trial using the DLBclass genetic classification tool shows Pola-R-CHP outperforms R-CHOP in a genetic subgroup known to have poor outcomes. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Pola-R-CHP May Reverse Outlook in High-Risk Lymphoma )

Apple Storegoogle play

Also on site :



Latest News